Literature DB >> 6626749

Estrogen receptor analysis in chronic lymphocytic leukemia.

S T Rosen, Z Maciorowski, F Wittlin, A L Epstein, L I Gordon, M S Kies, O Kucuk, H C Kwaan, H Vriesendorp, J N Winter.   

Abstract

Estrogen receptor (ER) determinations were performed on cytosol preparations of Ficoll-Hypaque density separated mononuclear cells from 11 patients with chronic lymphocytic leukemia (CLL). The presence of ER was noted in 8 of 11 specimens (73%). ER ranged from 431 fmole/mg to 4.3 fmole/mg cytosol protein. Two types of receptor subunits were observed at the 8S and 4S region of the sucrose gradient. In addition, 1 of 3 Epstein-Barr virus (EBV) transformed B-lymphoblastoid cell lines from healthy donors had a measurable amount of ER. Patient R.L., who was refractory to standard chemotherapy and radiation and was ER positive, experienced a minor response to Tamoxifen therapy, with subsequent loss of ER. The demonstration of ER in CLL suggests that this malignancy may have a hormone-dependent subpopulation of cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626749

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Effects of sex steroids on immunoglobulin M production by Epstein-Barr virus-transformed B-cell line SKW6-CL4.

Authors:  H Mori; M Sawairi; N Itoh; T Hanabayashi; T Tamaya
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12

2.  Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.

Authors:  Eric P Allain; Karin Venzl; Patrick Caron; Véronique Turcotte; David Simonyan; Michaela Gruber; Trang Le; Eric Lévesque; Chantal Guillemette; Katrina Vanura
Journal:  Ann Hematol       Date:  2018-05-21       Impact factor: 3.673

Review 3.  Second neoplasms in patients with chronic lymphocytic leukemia.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2004-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.